Exploring antibody repurposing for COVID-19: beyond presumed roles of therapeutic antibodies
Abstract The urgent need for a treatment of COVID-19 has left researchers with limited choice of either developing an effective vaccine or identifying approved/investigational drugs developed for other medical conditions for potential repurposing, thus bypassing long clinical trials. In this work, w...
Guardado en:
Autores principales: | Puneet Rawat, Divya Sharma, Ambuj Srivastava, Vani Janakiraman, M. Michael Gromiha |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/91d1b92f687040aebb2d043b3dfc7e60 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Exploring the sequence features determining amyloidosis in human antibody light chains
por: Puneet Rawat, et al.
Publicado: (2021) -
A Patent Review on the Therapeutic Application of Monoclonal Antibodies in COVID-19
por: Syed Mohammed Basheeruddin Asdaq, et al.
Publicado: (2021) -
The Road to Toxin-Targeted Therapeutic Antibodies
por: Thomas R. Kozel
Publicado: (2014) -
Questionable Efficacy of Therapeutic Antibodies in the Treatment of Anthrax
por: Jean-Nicolas Tournier, et al.
Publicado: (2019) -
Antibody or Anybody? Considering the Role of MRGPRX2 in Acute Drug-Induced Anaphylaxis and as a Therapeutic Target
por: Graham A. Mackay, et al.
Publicado: (2021)